Pharma companies turn to AI to speed up drug development, but hit hurdles
1 month, 2 weeks ago

Pharma companies turn to AI to speed up drug development, but hit hurdles

Live Mint  

When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals, its scientists thought they had a future lung medicine in their hands. British drug giant AstraZeneca’s use of AI for drug discovery across its portfolio shortened the time it took to design molecules from years to months and sometimes even weeks, the company’s chief data scientist, Jim Weatherall, said. “We now routinely integrate millions of data points from laboratory experiments, clinical studies and real-world data to better understand the drivers of disease and then use this knowledge to precisely design and target treatments," the company’s senior director of machine learning and AI, Patrick Schwab, said. “There is a data problem, a people problem and a bit of a strategy problem," said Thomas Clozel, chief executive and co-founder of Owkin, a Paris-based company that applies AI to medical research. Clozel pointed to a focus on short-term results among pharma companies and difficulties attracting and retaining data scientists as factors hindering the industry’s embrace of AI.

Data Pharma Drug Ai Pharma Companies Genentech Companies Turn  companies  turn  pharma  development  data  target  understand  problem  drug  drugs  speed  potential  hurdles  ai  experiments  hit

History of this topic

AI poised to revolutionise life sciences industry: EY-Parthenon and Microsoft Report
1 month ago

AI poised to revolutionise life sciences industry: EY-Parthenon and Microsoft Report

The Hindu  

Artificial Intelligence is revolutionising the life sciences industry, driving advancements in drug discovery, clinical trials, and precision medicine. The AI market in pharmaceuticals is projected to reach $16.49 billion by 2034, while AI-driven medical devices are expected to grow to $97.07 billion by 2028, marking a significant technological transformation in the sector. To address this, EY-Parthenon and Microsoft have introduced …

Experts discuss the role of AI in pharmaceutical research
1 month, 1 week ago

Experts discuss the role of AI in pharmaceutical research

The Hindu  

“Artificial intelligence is transforming drug discovery,” said M.N. He was speaking at Artificial Intelligence in Drug Discovery and Pharmaceutical Research-AICON’25, an international conference organised by SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, in collaboration with the Indian Pharmaceutical Association and the Indian Drug Manufacturers Association. Over 450 delegates, 13 national and international speakers, and leading pharmaceutical …

How will AI revolutionize drug development?
2 months, 2 weeks ago

How will AI revolutionize drug development?

The Hindu  

The potential of using artificial intelligence in drug discovery and development has sparked both excitemen t and skepticism among scientists, investors and the general public. AI-driven platforms like AlphaFold, which won the 2024 Nobel Prize for its ability to predict the structure of proteins and design new ones, showcase AI’s potential to accelerate drug development. They urge that “AI’s potential …

AI, machine learning to help Indian pharma industry to pivot on innovation
3 months ago

AI, machine learning to help Indian pharma industry to pivot on innovation

Live Mint  

New Delhi, Dec 26 As technological advancements like AI, machine learning and precision medicine revolutionise drug discovery, manufacturing and patient care, Indian pharmaceutical industry is set for a 'profound transformation' in 2025 with innovation, wider global access and improvement in quality becoming key themes for the future. The industry, which is expected to grow nearly two-fold to around USD 130 …

Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma
3 months, 3 weeks ago

Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma

Associated Press  

WASHINGTON — Artificial intelligence is changing the way companies do business — helping programmers write code and fielding customer service calls with chatbots. But the pharmaceutical industry is still waiting to see whether AI can tackle its biggest challenge: finding faster, cheaper ways to develop new drugs. Founded in 2018, Insitro is part of a growing field of AI companies …

Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma
3 months, 3 weeks ago

Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. But the pharmaceutical industry is still waiting to see …

When AI weds molecular biology, miracle treatments are born
9 months, 2 weeks ago

When AI weds molecular biology, miracle treatments are born

Live Mint  

To understand life," says The Economist, “you must understand proteins. DeepMind built on an existing product AlphaGo to study the sequences and structures of 100,000 proteins, and in four years brought it to a level where it can predict the folded shape of a protein right down to the molecular level. David Baker of the University of Washington has been …

The use of AI in drug development | Explained
10 months, 1 week ago

The use of AI in drug development | Explained

The Hindu  

Drug development is an expensive and time-consuming process. The development of two AI-based prediction tools, AlphaFold and RoseTTAFold, developed by researchers at DeepMind, a Google company, and the University of Washington, U.S., respectively, has provided a major scientific breakthrough in the last four years in the area of computational drug development. Second, the tools can only aid a single phase …

How AI is Revolutionizing Drug Development
55 years, 2 months ago

How AI is Revolutionizing Drug Development

Wired  

It costs an estimated $2.6B to bring a single molecule to market, of which 90 percent fail clinical studies. During this briefing, WIRED’s deputy global editorial director, Greg Williams spoke with Professor Yaakov Nahmias, founder of Tissue Dynamics, regarding the future of drug development and how it is dramatically increasing clinical success rates by using sensor-driven discovery. During a clinical …

Alphabet's new company to use AI for drug discovery
3 years, 4 months ago

Alphabet's new company to use AI for drug discovery

The Hindu  

Google's parent, Alphabet, has introduced a new company that will use Artificial Intelligence to accelerate drug discovery, and find cures for some of humanity’s most devastating diseases. "I'm thrilled to announce the creation of a new Alphabet company – Isomorphic Labs – a commercial venture with the mission to reimagine the entire drug discovery process from first principles with an …

Indian biomedical startup Elucidata raises $5 million in pre-series A funding round
4 years, 1 month ago

Indian biomedical startup Elucidata raises $5 million in pre-series A funding round

Firstpost  

Elucidata, an Indian Biomedical data management firm, on 28 January 2021 announced that it has raised $5 million in the pre-Series A funding round. The new funding round was captained by IvyCap Ventures followed by participants Hyperplane Venture Capital, a Bolton-based seed stage firm and a few other angel investors. In this scenario, it gives us immense pleasure to collaborate …

Discover Related